comparemela.com

Latest Breaking News On - James bylund - Page 3 : comparemela.com

TimesSquare Capital Management LLC Sells 102,636 Shares of Repligen Co (NASDAQ:RGEN)

TimesSquare Capital Management LLC Sells 102,636 Shares of Repligen Co (NASDAQ:RGEN)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Dana Investment Advisors Inc Decreases Stock Position in Repligen Co (NASDAQ:RGEN)

Dana Investment Advisors Inc. lowered its stake in Repligen Co. (NASDAQ:RGEN – Free Report) by 36.5% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,437 shares of the biotechnology company’s stock after selling 2,546 shares during the period. Dana Investment Advisors […]

Repligen Co (NASDAQ:RGEN) Shares Sold by Dana Investment Advisors Inc

Dana Investment Advisors Inc. lessened its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 36.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,437 shares of the biotechnology company’s stock after selling 2,546 shares during […]

WealthPlan Investment Management LLC Purchases Shares of 1,320 Repligen Co (NASDAQ:RGEN)

WealthPlan Investment Management LLC purchased a new stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,320 shares of the biotechnology company’s stock, valued at approximately $210,000. A number of other hedge […]

Repligen Co (NASDAQ:RGEN) to Post Q1 2024 Earnings of $0 30 Per Share, William Blair Forecasts

Repligen Co. (NASDAQ:RGEN – Free Report) – Stock analysts at William Blair cut their Q1 2024 earnings per share (EPS) estimates for shares of Repligen in a research report issued to clients and investors on Thursday, February 22nd. William Blair analyst M. Larew now forecasts that the biotechnology company will earn $0.30 per share for […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.